HomePLRX • NASDAQ
add
Pliant Therapeutics Inc
Previous close
$1.35
Day range
$1.30 - $1.41
Year range
$1.09 - $1.95
Market cap
81.42M USD
Avg Volume
711.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.78M | -62.91% |
Net income | -23.58M | 52.59% |
Net profit margin | — | — |
Earnings per share | -0.35 | 56.84% |
EBITDA | -19.41M | 63.28% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 190.94M | -46.32% |
Total assets | 225.23M | -43.26% |
Total liabilities | 44.02M | -52.60% |
Total equity | 181.20M | — |
Shares outstanding | 61.91M | — |
Price to book | 0.46 | — |
Return on assets | -19.70% | — |
Return on capital | -14.32% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -23.58M | 52.59% |
Cash from operations | -17.79M | 62.68% |
Cash from investing | 1.77M | -95.48% |
Cash from financing | -32.27M | -31,734.31% |
Net change in cash | -48.29M | -472.94% |
Free cash flow | -37.02M | -11.66% |
About
Founded
2015
Headquarters
Website
Employees
49
